or Try an Advanced Search...

    Clinical Trial Products Stocks List

    Symbol Grade Name % Change
    INCY A Incyte Corporation 2.71
    BIIB F Biogen Idec Inc. -0.12
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major
    Related Stock Lists: Clinical Trial Product Nasdaq 100 Psoriasis S&P 500 Alzheimer's Disease Autoimmune Disorders Biopharmaceutical Biotechnology Cd20 Chemical Compounds Chronic Lymphocytic Leukemia Degenerative Disease Diabetic Nephropathy Disability Hematologic Malignancies Hemophilia Idiopathic Pulmonary Fibrosis Immune Disorders Immunology Immunosuppressants

    Related ETFs - A few ETFs which own one or more of the above listed Clinical Trial Products stocks.

    Symbol Grade Name Weight
    BIS C ProShares UltraShort Nasdaq Biotechnology 8.21
    PBE C PowerShares Dynamic Biotech & Genome 7.64
    FBT A First Trust Amex Biotech Index Fund 6.7
    BBH D Market Vectors Biotech ETF 5.54
    XBI B SPDR S&P Biotech ETF 5.07
    View all Clinical Trial Products ETFs...
    Compare ETFs
    Compare BBH to XBI Compare BIS to FBT Compare PBE to BBH

        Clinical Trial Products Stocks Recent News

        Date Stock Title
        Nov 2 INCY What Moved Markets This Week
        Nov 1 BIIB Biogen partner Eisai completes FDA submissions for injectable Alzheimer’s therapy
        Nov 1 BIIB Biogen Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
        Oct 31 BIIB Biogen Q3 Earnings Review: Why I Remain Optimistic Despite Difficult Quarter
        Oct 31 BIIB Biogen down as Morgan Stanley cuts rating on sluggish Alzheimer’s drug launch
        Oct 31 BIIB Biogen slips as Morgan Stanley downgrades on Leqembi launch
        Oct 31 INCY Incyte: Q3 Earnings Ramping Up Growth To Jump The Patent Cliff
        Oct 31 BIIB Biogen Inc (BIIB) Q3 2024 Earnings Call Highlights: Navigating Revenue Declines and Strategic ...
        Oct 30 BIIB Eisai Presents Data on Benefits of Long-Term Administration of Dual-Acting Lecanemab at the 17th Clinical Trials for Alzheimer’s Disease (CTAD) Conference
        Oct 30 INCY Incyte's Jakafi Demand Is Strong, Analyst Upgrades Stock
        Oct 30 BIIB Biogen Beats on Q3 Earnings & Sales, Raises '24 EPS View
        Oct 30 BIIB Biogen and Neomorph enter molecular glue degrader deal
        Oct 30 BIIB Biogen (BIIB) Q3 2024 Earnings Call Transcript
        Oct 30 BIIB Biogen Inc. (BIIB) Q3 2024 Earnings Call Transcript
        Oct 30 BIIB Biogen raises 2024 EPS guidance with strong Q3 results
        Oct 30 BIIB Biogen Inc. 2024 Q3 - Results - Earnings Call Presentation
        Oct 30 BIIB Biogen Sinks. Why A Surprise Boost From Its Alzheimer's Drug Wasn't Enough.
        Oct 30 BIIB SAGE's Q3 Loss Wider Than Expected, Revenues Rise Y/Y, Stock Down
        Oct 30 BIIB Biogen (BIIB) Reports Q3 Earnings: What Key Metrics Have to Say
        Oct 30 BIIB Biogen Inc. (BIIB) Q3 Earnings and Revenues Surpass Estimates
        Related Industries: Biotechnology Drug Manufacturers - Major
        Related Stock Lists: Clinical Trial Product Nasdaq 100 Psoriasis S&P 500 Alzheimer's Disease Autoimmune Disorders Biopharmaceutical Biotechnology Cd20 Chemical Compounds Chronic Lymphocytic Leukemia Degenerative Disease Diabetic Nephropathy Disability Hematologic Malignancies Hemophilia Idiopathic Pulmonary Fibrosis Immune Disorders Immunology Immunosuppressants
        Clinical Trial Products

        Clinical trial products are any products used in clinical trials, such as drugs, medical devices, or biologics. These products are tested in clinical trials to determine their safety and efficacy for treating a particular medical condition. Clinical trial products must meet strict regulatory requirements before they can be approved for use in humans.

        Browse All Tags